FIGURE 1.
Asprosin concentration in blood plasma during the control (CON) tests and the Nordic walking stage (NW). Data are presented as medians (Me) and quartiles (Q1, Q3); p < 0.05 – statistically significant difference with regard to baseline value at a given stage.